
-
AI videos push Combs trial misinformation, researchers say
-
UK govt guts key welfare reforms to win vote after internal rebellion
-
Polish supreme court ratifies nationalist's presidential vote win
-
Macron, Putin discuss Iran, Ukraine in first talks since 2022
-
French league launches own channel to broadcast Ligue 1
-
Man City left to reflect on Club World Cup exit as tournament opens up
-
Shock study: Mild electric stimulation boosts math ability
-
Europe swelters as surprise early summer heatwave spreads
-
Third seed Zverev stunned at Wimbledon
-
Israel expands Gaza campaign ahead of Netanyahu's US visit
-
Gaza mourns those killed in Israeli strike on seafront cafe
-
Rubio hails end of USAID as Bush, Obama deplore cost in lives
-
Berlusconi family sell Monza football club to US investment fund
-
UN aid meeting seeks end to Global South debt crisis
-
Trump ramps up Musk feud with deportation threat
-
French paparazzi boss handed 18-month suspended sentence for blackmail
-
Gilgeous-Alexander agrees record $285 mln extension: reports
-
Tearful former champion Kvitova loses on Wimbledon farewell
-
IMF urges Swiss to strengthen bank resilience
-
Sri Lanka eye top-three spot in ODI rankings
-
Trump hails new 'Alligator Alcatraz' migrant detention center
-
US Senate approves divisive Trump spending bill
-
Krejcikova toughs it out in Wimbledon opener, Sinner cruises
-
UK govt braces for crunch welfare reforms vote amid major rebellion
-
Shifting to Asia, Rubio meets Quad and talks minerals
-
Stocks diverge while tracking US trade deal prospects
-
Bruce Lee Club closes archive doors citing operating costs
-
Trump ramps up Musk feud with deportation, DOGE threats
-
BTS announces comeback for spring 2026
-
Beating England without Bumrah 'not impossible' for India captain Gill
-
Krejcikova battles back against rising star Eala to win Wimbledon opener
-
US Republicans close in on make-or-break Trump mega-bill vote
-
Arsenal sign goalkeeper Kepa from Chelsea
-
Olympic champion Zheng knocked out of Wimbledon
-
Line judges missed at Wimbledon as AI takes their jobs
-
Tshituka to make Test debut as Springboks change five
-
'Remember Charlie Hebdo!' Protesters seethe at Istanbul magazine
-
Top seed Sinner eases into Wimbledon second round
-
Stocks retreat as profit-taking follows Wall Street records
-
Israel expands campaign in Gaza ahead of Netanyahu's US visit
-
Barcelona's Ansu Fati aims to kick-start career in Monaco
-
Bordeaux-Begles drawn with Northampton in Champions Cup final repeat
-
Sean Combs trial: jurors seek verdict for a second day
-
Trump says will 'take a look' at deporting Musk
-
Greece starts charging tourist tax on cruises
-
Trump heads for 'Alligator Alcatraz' migrant detention center
-
US Senate push to pass Trump's unpopular spending bill enters second day
-
England captain Stokes relishing Pant battle in India series
-
Ukraine hits Russian city deep behind front line, leaves three dead
-
Hinault backs 'complete rider' Pogacar for Tour de France glory

Moderna rebuked over plan to hike Covid vaccine to $130
Moderna's chief executive on Wednesday defended the US company's plan to quadruple the price of its lifesaving Covid vaccine to as much as $130 per dose as soon as government stockpiles run out.
Democratic Senator Bernie Sanders lashed out at the price hike, denouncing the "unprecedented level of corporate greed" in the pharmaceutical industry. "And that is certainly true with Moderna," Sanders said.
Moderna has so far charged between about $15 and $26 for doses of its vaccine, according to the Kaiser Family Foundation.
The US government subsidized $1.7 billion of Moderna's research at the start of the pandemic and then purchased $10 billion worth of vaccine, Sanders said at a Senate hearing where the company's CEO Stephane Bancel was testifying.
Sanders said Moderna was "thanking the taxpayers of the United States" by more than quadrupling the vaccine's price "at a time when it costs less than $3 to manufacture."
Sanders noted several times at the hearing that Moderna conducted buybacks of its own stock and paid its own executives at its Cambridge, Massachusetts, headquarters handsomely.
Bancel defended Moderna, saying the distribution system will change completely when the US government lifts a state of health emergency, perhaps as soon as May.
Up until now, Moderna had only one customer, distributed its vaccine to only a few warehouses and did not have to pay for the cost of expired doses.
By switching to a more traditional marketing approach, "we're going to have 10,000 customers" and have to "manage to deliver to 60,000 pharmacies, doctors' offices and hospitals," he added.
Currently distributed in multidose vials, the vaccine will be sold mostly in single-dose vials or directly in prefilled syringes. And Moderna will have to take care of the unsold doses.
The company expects a "90 percent reduction in demand," Bancel said. "We are losing economies of scale. We must assume the wastage risk and cost that the US government used to assume."
Moderna also pledged to set up a program so that the uninsured or underinsured would not have to pay anything.
When pressed by Sanders about the possibility of the company lowering its price for government-run health insurance programs, Bancel said discussions were underway with all customers.
P.Martin--AMWN